Are the pharmacological effects of L-prolyl-L-leucylglycinamide (PLG) mediated through specific receptor mechanisms?
- 1 January 1983
- journal article
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 7 (4-6) , 739-742
- https://doi.org/10.1016/0278-5846(83)90056-8
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Binding studies of L-Prolyl-L-leucyl-glycinamide (PLG), a novel antiparkinsonian agent, in normal human brainPharmacological Research Communications, 1983
- CNS putative L-prolyl-L-leucyl-glycinamide (PLG) receptors, brain and lymphocyte dopamine receptorsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1982
- Neuroleptic Drug-Induced Dopamine Receptor Supersensitivity: Antagonism by L-Prolyl-L-Leucyl-GlycinamideScience, 1981
- Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine/neuroleptic receptor bindingsPeptides, 1981